Literature DB >> 29270415

A step forward in disease modelling for mitochondrial diseases.

Filippo Zambelli1, Claudia Spits1.   

Abstract

Entities:  

Year:  2017        PMID： 29270415      PMCID： PMC5723745          DOI： 10.21037/sci.2017.10.06

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN： 2306-9759


× No keyword cloud information.
  15 in total

1.  From Dish to Bedside: Lessons Learned While Translating Findings from a Stem Cell Model of Disease to a Clinical Trial.

Authors:  John McNeish; Jason P Gardner; Brian J Wainger; Clifford J Woolf; Kevin Eggan
Journal:  Cell Stem Cell       Date:  2015-07-02       Impact factor: 24.633

2.  Genetic background influences mitochondrial function: modeling mitochondrial disease for therapeutic development.

Authors:  Paule Bénit; Riyad El-Khoury; Manuel Schiff; Annie Sainsard-Chanet; Pierre Rustin
Journal:  Trends Mol Med       Date:  2010-04-09       Impact factor: 11.951

3.  Human iPSC-Derived Neural Progenitors Are an Effective Drug Discovery Model for Neurological mtDNA Disorders.

Authors:  Carmen Lorenz; Pierre Lesimple; Raul Bukowiecki; Annika Zink; Gizem Inak; Barbara Mlody; Manvendra Singh; Marcus Semtner; Nancy Mah; Karine Auré; Megan Leong; Oleksandr Zabiegalov; Ekaterini-Maria Lyras; Vanessa Pfiffer; Beatrix Fauler; Jenny Eichhorst; Burkhard Wiesner; Norbert Huebner; Josef Priller; Thorsten Mielke; David Meierhofer; Zsuzsanna Izsvák; Jochen C Meier; Frédéric Bouillaud; James Adjaye; Markus Schuelke; Erich E Wanker; Anne Lombès; Alessandro Prigione
Journal:  Cell Stem Cell       Date:  2017-01-26       Impact factor: 24.633

Review 4.  Concise Review: Induced Pluripotent Stem Cell-Based Drug Discovery for Mitochondrial Disease.

Authors:  Gizem Inak; Carmen Lorenz; Pawel Lisowski; Annika Zink; Barbara Mlody; Alessandro Prigione
Journal:  Stem Cells       Date:  2017-05-22       Impact factor: 6.277

5.  Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy.

Authors:  Stefania Corti; Monica Nizzardo; Chiara Simone; Marianna Falcone; Martina Nardini; Dario Ronchi; Chiara Donadoni; Sabrina Salani; Giulietta Riboldi; Francesca Magri; Giorgia Menozzi; Clara Bonaglia; Federica Rizzo; Nereo Bresolin; Giacomo P Comi
Journal:  Sci Transl Med       Date:  2012-12-19       Impact factor: 17.956

6.  Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration.

Authors:  Xing Guo; Marie-Helene Disatnik; Marie Monbureau; Mehrdad Shamloo; Daria Mochly-Rosen; Xin Qi
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 14.808

7.  Induced pluripotent stem cells with a mitochondrial DNA deletion.

Authors:  Anne B C Cherry; Katelyn E Gagne; Erin M McLoughlin; Anna Baccei; Bryan Gorman; Odelya Hartung; Justine D Miller; Jin Zhang; Rebecca L Zon; Tan A Ince; Ellis J Neufeld; Paul H Lerou; Mark D Fleming; George Q Daley; Suneet Agarwal
Journal:  Stem Cells       Date:  2013-07       Impact factor: 6.277

Review 8.  Pluripotent stem cells in disease modelling and drug discovery.

Authors:  Yishai Avior; Ido Sagi; Nissim Benvenisty
Journal:  Nat Rev Mol Cell Biol       Date:  2016-01-28       Impact factor: 94.444

9.  Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy.

Authors:  Dhruv Sareen; Allison D Ebert; Brittany M Heins; Jered V McGivern; Loren Ornelas; Clive N Svendsen
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

Review 10.  Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies.

Authors:  Heather M Wilkins; Steven M Carl; Russell H Swerdlow
Journal:  Redox Biol       Date:  2014-04-01       Impact factor: 11.799
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.